儿童非结核分枝杆菌病的诊断和治疗进展

doi:10.3969/j.issn.1000-6621.2021.09.021

中国防痨杂志 ›› 2021, Vol. 43 ›› Issue (9): 979-982.doi: 10.3969/j.issn.1000-6621.2021.09.021

• 综述 • 上一篇

儿童非结核分枝杆菌病的诊断和治疗进展

郑惠文, 申阿东()

100045 国家儿童医学中心国家呼吸系统疾病临床医学研究中心教育部儿科重大疾病研究重点实验室首都医科大学附属北京儿童医院北京市儿科研究所儿童呼吸道感染性疾病北京市重点实验室呼吸疾病研究室

收稿日期:2021-06-08 出版日期:2021-09-10 发布日期:2021-09-07
通信作者: 申阿东 E-mail:shenad18@126.com
基金资助:
首都卫生发展科研专项(2020-1-2091)

The diagnosis and treatment of non-tuberculous mycobacterium disease in children

ZHENG Hui-wen, SHEN A-dong()

Beijing Key Laboratory of Pediatric Respiratory Infection Diseases, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, National Key Discipline of Pediatrics (Capital Medical University), Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing 100045, China

Received:2021-06-08 Online:2021-09-10 Published:2021-09-07
Contact: SHEN A-dong E-mail:shenad18@126.com

摘要/Abstract

摘要：

非结核分枝杆菌(non-tuberculous mycobacterium,NTM)病与结核病相比有相似的临床症状,且致病菌种繁多,鉴别诊断困难,增加了治疗的难度。作者就儿童NTM病的流行病学和临床症状,以及儿童NTM病的诊断和治疗方法进行了综述。

关键词: 分枝杆菌,非典型性, 儿童, 诊断,鉴别, 治疗

Abstract:

Compared with tuberculosis, nontuberculous mycobacterium (NTM) disease with various pathogenic bacteria infections has similar clinical symptoms, which increases the difficulties of differential diagnosis and treatment. In this study, the epidemiological features of NTM and clinical symptoms of NTM in children, as well as its diagnosis and treatment methods were reviewed.

Key words: Mycobacteria,atypical, Child, Diagnosis,differential, Treatment

郑惠文, 申阿东. 儿童非结核分枝杆菌病的诊断和治疗进展[J]. 中国防痨杂志, 2021, 43(9): 979-982. doi: 10.3969/j.issn.1000-6621.2021.09.021

ZHENG Hui-wen, SHEN A-dong. The diagnosis and treatment of non-tuberculous mycobacterium disease in children[J]. Chinese Journal of Antituberculosis, 2021, 43(9): 979-982. doi: 10.3969/j.issn.1000-6621.2021.09.021

参考文献 26

[1]	Saxena S, Spaink HP, Forn-Cuní G. Drug Resistance in Nontuberculous Mycobacteria: Mechanisms and Models. Biology (Basel), 2021, 10(2):96. doi: 10.3390/biology10020096. doi: 10.3390/biology10020096
[2]	Tebruegge M, Pantazidou A, MacGregor D, et al. Nontuberculous Mycobacterial Disease in Children-Epidemiology, Diagnosis & Management at a Tertiary Center. PLoS One, 2016, 11(1):e0147513. doi: 10.1371/journal.pone.0147513. doi: 10.1371/journal.pone.0147513 URL
[3]	Haverkamp MH, Arend SM, Lindeboom JA, et al. Nontuberculous mycobacterial infection in children: a 2-year prospective surveillance study in the Netherlands. Clin Infect Dis, 2004, 39(4):450-456. doi: 10.1086/422319. doi: 10.1086/422319 pmid: 15356803
[4]	Pham-Huy A, Robinson JL, Tapiéro B, et al. Current trends in nontuberculous mycobacteria infections in Canadian children: A pediatric investigators collaborative network on infections in Canada (PICNIC) study. Paediatr Child Health, 2010, 15(5):276-282. doi: 10.1093/pch/15.5.276. doi: 10.1093/pch/15.5.276 URL
[5]	Reuss AM, Wiese-Posselt M, Weissmann B, et al. Incidence rate of nontuberculous mycobacterial disease in immunocompetent children: a prospective nationwide surveillance study in Germany. Pediatr Infect Dis J, 2009, 28(7):642-644. doi: 10.1097/INF.0b013e3181978e8e. doi: 10.1097/INF.0b013e3181978e8e URL
[6]	Asiimwe BB, Bagyenzi GB, Ssengooba W, et al. Species and genotypic diversity of non-tuberculous mycobacteria isolated from children investigated for pulmonary tuberculosis in rural Uganda. BMC Infect Dis, 2013, 13:88. doi: 10.1186/1471-2334-13-88. doi: 10.1186/1471-2334-13-88 pmid: 23413873
[7]	王宇. 全国第五次结核病流行病学抽样调查资料汇编. 北京: 军事医学科学出版社, 2011: 15-18.
[8]	Zimmermann P, Curtis N, Tebruegge M. Nontuberculous mycobacterial disease in childhood-update on diagnostic approaches and treatment. J Infect, 2017, 74 Suppl 1: S136-S142. doi: 10.1016/S0163-4453(17)30204-9. doi: 10.1016/S0163-4453(17)30204-9
[9]	Loizos A, Soteriades ES, Pieridou D, et al. Lymphadenitis by non-tuberculous mycobacteria in children. Pediatr Int, 2018, 60(12):1062-1067. doi: 10.1111/ped.13708. doi: 10.1111/ped.13708
[10]	López-Varela E, García-Basteiro AL, Santiago B, et al. Non-tuberculous mycobacteria in children: muddying the waters of tuberculosis diagnosis. Lancet Respir Med, 2015, 3(3):244-256. doi: 10.1016/S2213-2600(15)00062-4. doi: 10.1016/S2213-2600(15)00062-4 URL
[11]	Danielides V, Patrikakos G, Moerman M, et al. Diagnosis, management and surgical treatment of non-tuberculous mycobacterial head and neck infection in children. ORL J Otorhinolaryngol Relat Spec, 2002, 64(4):284-289. doi: 10.1159/000064138. doi: 10.1159/000064138 URL
[12]	Willemse SH, Oomens MAEM, De Lange J, et al. Diagnosing nontuberculous mycobacterial cervicofacial lymphadenitis in children: A systematic review. Int J Pediatr Otorhinolaryngol, 2018, 112:48-54. doi: 10.1016/j.ijporl.2018.06.034. doi: 10.1016/j.ijporl.2018.06.034 URL
[13]	Chung J, Ince D, Ford BA, et al. Cutaneous Infections Due to Nontuberculosis Mycobacterium: Recognition and Management. Am J Clin Dermatol, 2018, 19(6):867-878. doi: 10.1007/s40257-018-0382-5. doi: 10.1007/s40257-018-0382-5 pmid: 30168084
[14]	Santa Cruz DJ, Strayer DS. The histologic spectrum of the cutaneous mycobacterioses. Hum Pathol, 1982, 13(5):485-495. doi: 10.1016/s0046-8177(82)80032-4. doi: 10.1016/s0046-8177(82)80032-4 pmid: 6804365
[15]	Lu M, Saddi V, Britton PN, et al. Disease caused by non-tuberculous mycobacteria in children with cystic fibrosis. Paediatr Respir Rev, 2019, 29:42-52. doi: 10.1016/j.prrv.2018.05.001. doi: 10.1016/j.prrv.2018.05.001
[16]	Martiniano SL, Davidson RM, Nick JA. Nontuberculous mycobacteria in cystic fibrosis: Updates and the path forward. Pediatr Pulmonol, 2017, 52(S48):S29-S36. doi: 10.1002/ppul.23825. doi: 10.1002/ppul.23825 URL
[17]	Morgan MB, Reves RR, Wilson ML, et al. Comparison of BACTEC 12B vs solid media for the recovery of Mycobacterium avium complex from blood cultures in AIDS patients. Diagn Microbiol Infect Dis, 1997, 28(1):45-48. doi: 10.1016/s0732-8893(97)89159-6. doi: 10.1016/s0732-8893(97)89159-6 URL
[18]	Schoenfeld N, Haas W, Richter E, et al. Recommendations of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the Diagnosis and Treatment of Non-tuberculous Mycobacterioses. Pneumo-logie, 2016, 70(4):250-276. doi: 10.1055/s-0041-111494. doi: 10.1055/s-0041-111494
[19]	Zimmermann P, Tebruegge M, Curtis N, et al. The management of non-tuberculous cervicofacial lymphadenitis in children: A systematic review and meta-analysis. J Infect, 2015, 71(1):9-18. doi: 10.1016/j.jinf.2015.02.010. doi: 10.1016/j.jinf.2015.02.010 pmid: 25727993
[20]	Torretta S, Gaffuri M, Ibba T, et al. Surgical treatment of non-tuberculous mycobacterial lymphadenitis in children: Our experience and a narrative review. Int J Immunopathol Pharmacol, 2018, 32:2058738418806413. doi: 10.1177/2058738418806413. doi: 10.1177/2058738418806413
[21]	Meoli A, Deolmi M, Iannarella R, et al. Non-Tuberculous Mycobacterial Diseases in Children. Pathogens, 2020, 9(7):553. doi: 10.3390/pathogens9070553. doi: 10.3390/pathogens9070553 URL
[22]	Andrew EC, Connell T, Robinson P, et al. Pulmonary Mycobacterium abscessus complex in children with cystic fibrosis: A practical management guideline. J Paediatr Child Health, 2019, 55(5):502-511. doi: 10.1111/jpc.14427. doi: 10.1111/jpc.14427 URL
[23]	Lindeboom JA. Conservative wait-and-see therapy versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children. Clin Infect Dis, 2011, 52(2):180-184. doi: 10.1093/cid/ciq070. doi: 10.1093/cid/ciq070 pmid: 21288841
[24]	Shafran SD, Singer J, Zarowny DP, et al. A Comparison of Two Regimens for the Treatment of Mycobacterium avium Complex Bacteremia in AIDS: Rifabutin, Ethambutol, and Clarithromycin versus Rifampin, Ethambutol, Clofazimine, and Ciprofloxacin. N Engl J Med, 1996, 335:377-383. doi: 10.1056/NEJM199608083350602. doi: 10.1056/NEJM199608083350602 URL
[25]	Karakousis PC, Moore RD, Chaisson RE. Mycobacterium avium complex in patients with HIV infection in the era of highly activeantiretroviral therapy. Lancet Infect Dis, 2004, 4:557-565. doi: 10.1016/S1473-3099(04)01130-2. doi: 10.1016/S1473-3099(04)01130-2 pmid: 15336223
[26]	Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med, 2007, 175(4):367-416. doi: 10.1164/rccm.200604-571ST. doi: 10.1164/rccm.200604-571ST URL

儿童非结核分枝杆菌病的诊断和治疗进展

The diagnosis and treatment of non-tuberculous mycobacterium disease in children

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 26

相关文章 15

编辑推荐

Metrics

本文评价

友情链接

[1]	首都医科大学附属北京胸科医院, 《中国防痨杂志》编辑委员会. 抗结核药治疗药物监测临床应用专家共识[J]. 中国防痨杂志, 2021, 43(9): 867-873.
[2]	刘芳, 饶小春, 马渝燕, 孟辰芳, 潘跃娜, 焦安夏, 申阿东. 经支气管镜介入治疗儿童淋巴结瘘型气管支气管结核有效性评价[J]. 中国防痨杂志, 2021, 43(8): 826-831.
[3]	陈珊珊, 唐晓军, 唐小莉, 戴广川, 曾谊, 张侠. 动脉栓塞介入治疗肺结核并发肺动脉假性动脉瘤伴大咯血三例并文献复习[J]. 中国防痨杂志, 2021, 43(8): 832-837.
[4]	王亚翠, 孙琳, 申阿东. Xpert MTB/RIF Ultra在儿童结核病诊断中的应用进展[J]. 中国防痨杂志, 2021, 43(8): 843-846.
[5]	林岩, 邓国防. 糖尿病并发结核病治疗中多学科合作应注意的问题[J]. 中国防痨杂志, 2021, 43(7): 649-652.
[6]	祁雪, 吴喜蓉, 郭雅洁, 王咏红, 马琦, 陈玉莹, 孙琳, 申阿东. 住院儿童结核分枝杆菌潜伏感染筛查情况分析[J]. 中国防痨杂志, 2021, 43(7): 653-658.
[7]	覃瑶, 蔡青山, 鲍志坚. 21例体外受精-胚胎移植后妊娠并发结核病患者的临床特征及预后分析[J]. 中国防痨杂志, 2021, 43(7): 682-688.
[8]	冯燕, 李颖, 李强, 张丹, 林虎, 郭现利. 食管固有动脉参与肺结核大咯血供血的动脉栓塞研究[J]. 中国防痨杂志, 2021, 43(7): 689-693.
[9]	. 卡介苗不良反应临床处理指南[J]. 中国防痨杂志, 2021, 43(6): 532-538.
[10]	方敏, 石艳, 段莉, 石小梅, 全舒婷, 王亚翠, 彭小姗, 郏继航, 綦辉, 焦伟伟, 朱渝, 孙琳. GeneXpert MTB/RIF Ultra检测胃液标本对儿童肺结核的诊断价值[J]. 中国防痨杂志, 2021, 43(6): 584-589.
[11]	薛海滨, 罗小波, 孙飞, 简伟, 李金龙. 通道下后方经椎间孔入路行病灶清除联合椎间植骨内固定术治疗腰椎结核的效果分析[J]. 中国防痨杂志, 2021, 43(5): 457-462.
[12]	苗瑞瑞, 辛士珍, 唐亮, 宁华英, 鲍玉成, 张文龙. 加速康复外科理念指导下的围手术期营养治疗在脊柱结核诊疗中的应用[J]. 中国防痨杂志, 2021, 43(5): 468-474.
[13]	杨虹, 马进宝, 任斐, 李雪, 武延琴, 李荣, 谭淦纹, 杨翰. 分类评估对初治耐多药肺结核患者应用初治标准化疗方案的效果分析[J]. 中国防痨杂志, 2021, 43(5): 495-500.
[14]	马艳, 高微微. 今非昔比:重视复治肺结核的合理施治[J]. 中国防痨杂志, 2021, 43(4): 313-317.
[15]	戈启萍, 杜建, 舒嶶, 马艳, 马丽萍, 赵彩燕, 陈瑜晖, 张立杰, 黄学锐, 韩喜琴, 陈盛玉, 王飞, 李波, 曹文利, 刘倩颖, 陈东进, 石莲, 王鑫, 黎友伦, 杨尚鹏, 彭章丽, 吴超, 欧阳兵, 王芙蓉, 李钋, 吴湘, 席秀娥, 冷学艳, 张海晴, 李华, 李鹃, 杨澄清, 张朋, 崔洪哲, 谢莉, 刘宇红, 李亮, 高微微. 优化方案治疗复治药物敏感肺结核的疗效评价[J]. 中国防痨杂志, 2021, 43(4): 328-334.